Geron Corporation GERN
1.26
0.00
0.00%
as of 25 Sep
- Market cap
- $815.9M
- P/E
- 0.0×
Follow GERN
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
0.00 | 0.00 | 0.00 | 0.00 |
+8 more quarters Free account |
P/S ratio |
4.20 | 5.09 | 4.79 | 4.98 | |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | |
P/Operating CF |
(54.24) | (15.85) | (39.88) | (67.32) | |
P/B ratio |
3.93 | 4.35 | 3.90 | 3.67 | |
Price to Tangible BV |
3.93 | 4.35 | 3.90 | 3.67 | |
EV/Sales |
3.65 | 4.46 | 3.87 | 3.94 | |
EV/EBITDA |
0.00 | 0.00 | 0.00 | 0.00 | |
EV/Operating CF |
(6.53) | (6.94) | (6.41) | (5.43) | |
EV/FCF |
(6.51) | (6.92) | (6.40) | (5.44) | |
Quick Ratio |
5.07 | 4.87 | 3.58 | 4.79 | |
Current Ratio |
6.92 | 6.78 | 4.66 | 5.96 | |
Net Debt/EBITDA |
14.52 | 650.34 | 9.09 | 17.74 | |
Debt/Assets |
23.15% | 22.44% | 20.95% | 21.02% | |
Debt/Equity |
0.55 | 0.52 | 0.53 | 0.48 | |
Asset Turnover |
0.38 | 0.36 | 0.32 | 0.36 | |
Operating CF/Net income |
0.95 | 17.27 | 0.76 | 0.74 | |
Capex/Depreciation |
2.86 | 0.55 | 0.00 | (0.09) | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
38.33% | 28.85% | 28.22% | 44.61% | |
Selling, General and Administrative Expense of Revenue |
67.61% | 68.34% | 86.78% | 82.58% | |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | |
Share Based Compensation of Revenue |
8.61% | 9.48% | 12.06% | 14.34% | |
Graham Net Nets |
0.22 | 0.19 | 0.20 | 0.22 | |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | |
Earnings Yield |
(8.23%) | (7.07%) | (9.85%) | (8.76%) | |
Free Cash Flow Yield |
(13.37%) | (12.66%) | (12.62%) | (14.53%) | |
Revenue per Share |
0.09 | 0.08 | 0.07 | 0.07 | |
Operating CF per Share |
(0.02) | (0.09) | (0.03) | (0.02) | |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Free Cash Flow per Share |
(0.02) | (0.09) | (0.03) | (0.02) | |
Cash per Share |
0.45 | 0.47 | 0.54 | 0.57 | |
Shareholders Equity per Share |
0.33 | 0.34 | 0.34 | 0.37 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
0.33 | 0.34 | 0.34 | 0.37 | |
Free Cash Flow |
(16.05) | (63.16) | (22.07) | (13.49) | |
Working Capital |
416.01 | 424.96 | 408.73 | 434.63 | |
Capital Expenditures |
(0.22) | (0.25) | 0.00 | 0.09 | |
Net Current Asset Value |
185.94 | 193.52 | 175.60 | 203.67 | |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.00 | |
Net Profit Margin |
(29.02%) | (7.03%) | (60.11%) | (39.02%) | |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | |
| Other line items | |||||
Average Receivables |
46.43 | 39.04 | 39.01 | 33.87 | |
Average Payables |
8.52 | 10.38 | 9.93 | 12.42 | |
Average Inventory |
96.36 | 94.75 | 77.68 | 57.85 | |
Average Assets |
537.10 | 548.29 | 582.16 | 506.17 | |
Average Common Equity |
239.07 | 248.67 | 253.10 | 270.50 |
Columns are period end dates